Core Ingredient: LL-37 (the active form of the human body's natural antimicrobial peptide Cathelicidin).
Common Specifications: Usually in high-purity lyophilized powder form, commonly packaged in 1mg, 5mg, or 10mg packets.
Physical Properties: White sterile lyophilized powder, sensitive to light and temperature, requires low-temperature and light-protected storage.
Dissolving Medium: Generally reconstituted using sterile antibacterial water for injection.
LL-37 is hailed as a "versatile" agent of the human immune system. It is not merely a simple bactericide, but a core defense molecule maintaining homeostasis: Broad-spectrum physical killing: It carries a positive charge, allowing it to precisely adhere to the surface of negatively charged bacteria, fungi, and even viruses like a magnet, directly piercing their cell membranes and causing pathogens to "leak" and die. This physical attack method makes it extremely difficult for microorganisms to develop resistance.
Immune Balance Master: It can keenly sense infection signals and quickly summon immune forces such as neutrophils to the front lines; simultaneously, it can neutralize endotoxins, preventing the immune system from overreacting and triggering a "cytokine storm," finding a perfect balance between killing the enemy and protecting its own tissues.
Wound Repair Accelerator: During wound healing, LL-37 promotes angiogenesis and epithelial cell migration, acting like a commander-in-chief at a construction site, accelerating the reconstruction and repair of damaged tissues.
Low Risk of Drug Resistance: Unlike traditional antibiotics that target specific points, LL-37 kills bacteria through a "lower-dimensional attack"-damaging the cell membrane-making it difficult for even superbugs to develop defense mechanisms.
Versatile Cross-Sector Capabilities: In addition to anti-infection, it has shown remarkable potential in antiviral (e.g., interfering with coronavirus invasion), anti-tumor (inducing cancer cell apoptosis), and regulating chronic inflammation.
Extremely Low Human-Derived Rejection: As a defensive peptide produced by the human body itself, it has excellent biocompatibility and is theoretically safer than exogenous drugs, less likely to cause severe allergic reactions.
Highly susceptible to inactivation in vivo: This is its biggest drawback. Natural LL-37 is rapidly degraded by proteases in vivo, resulting in a very short half-life and significantly reducing the effective concentration reaching the lesion.
Double-edged sword effect of concentration: At low concentrations, it acts as a protector, but at high concentrations, it may be toxic to normal human cells. Furthermore, in certain complex infection environments (such as some urinary tract infections), it may be utilized by bacteria to worsen the condition.
High production and application costs: The preparation process for high-purity synthetic peptides is complex and expensive. The current lack of mature and stable delivery systems (such as nanocarriers) limits its clinical application.
Combating drug-resistant bacterial infections: Exploring new pathways to combat pneumonia or skin infections caused by superbugs such as methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.
Repairing slow-healing wounds: Studying its specific efficacy in promoting angiogenesis and accelerating epithelialization for chronic, non-healing wounds such as diabetic foot ulcers and severe burns. Anti-tumor and anti-inflammatory exploration: Exploring its potential value in selectively inhibiting cancer cell growth and regulating the intestinal microenvironment in inflammation-related cancer models such as colon cancer.
Contraindications: Pregnant women, breastfeeding women, minors, and individuals allergic to peptides are strictly prohibited from contact.
Strict storage conditions: The lyophilized powder must be stored frozen at -20°C; the reconstituted solution is extremely unstable and must be refrigerated and used within a short period to avoid repeated freeze-thaw cycles that could cause peptide chain breakage and inactivation.
Maintain a healthy respect: Although LL-37 shows impressive performance in laboratory data, it still has a long way to go before mature clinical application. Current research is still in its early stages; it should not be blindly adopted as a routine treatment.
Hot Tags: High-Quality Peptides LL37 5mg/vial, China High-Quality Peptides LL37 5mg/vial manufacturers, suppliers, factory
